Cargando…
Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647]
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846453/ https://www.ncbi.nlm.nih.gov/pubmed/36685732 http://dx.doi.org/10.1016/j.curtheres.2022.100664 |
| _version_ | 1784871180116688896 |
|---|---|
| author | Shalaby, Mohammed Fouad Abd El Latif, Hekma A. Yamani, Mohamed El Galal, May Ahmed Kamal, Sherifa Sindi, Ikhlas |
| author_facet | Shalaby, Mohammed Fouad Abd El Latif, Hekma A. Yamani, Mohamed El Galal, May Ahmed Kamal, Sherifa Sindi, Ikhlas |
| author_sort | Shalaby, Mohammed Fouad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9846453 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98464532023-01-19 Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647] Shalaby, Mohammed Fouad Abd El Latif, Hekma A. Yamani, Mohamed El Galal, May Ahmed Kamal, Sherifa Sindi, Ikhlas Curr Ther Res Clin Exp Corrigendum Elsevier 2022-04-02 /pmc/articles/PMC9846453/ /pubmed/36685732 http://dx.doi.org/10.1016/j.curtheres.2022.100664 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Shalaby, Mohammed Fouad Abd El Latif, Hekma A. Yamani, Mohamed El Galal, May Ahmed Kamal, Sherifa Sindi, Ikhlas Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647] |
| title | Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647] |
| title_full | Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647] |
| title_fullStr | Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647] |
| title_full_unstemmed | Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647] |
| title_short | Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647] |
| title_sort | corrigendum to ``protective role of sarpogrelate in combination with bromocriptine and cabergoline for treatment of diabetes in alloxan-induced diabetic rats'' [current therapeutic research volume 95, 2021, 100647] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846453/ https://www.ncbi.nlm.nih.gov/pubmed/36685732 http://dx.doi.org/10.1016/j.curtheres.2022.100664 |
| work_keys_str_mv | AT shalabymohammedfouad corrigendumtoprotectiveroleofsarpogrelateincombinationwithbromocriptineandcabergolinefortreatmentofdiabetesinalloxaninduceddiabeticratscurrenttherapeuticresearchvolume952021100647 AT abdellatifhekmaa corrigendumtoprotectiveroleofsarpogrelateincombinationwithbromocriptineandcabergolinefortreatmentofdiabetesinalloxaninduceddiabeticratscurrenttherapeuticresearchvolume952021100647 AT yamanimohamedel corrigendumtoprotectiveroleofsarpogrelateincombinationwithbromocriptineandcabergolinefortreatmentofdiabetesinalloxaninduceddiabeticratscurrenttherapeuticresearchvolume952021100647 AT galalmayahmed corrigendumtoprotectiveroleofsarpogrelateincombinationwithbromocriptineandcabergolinefortreatmentofdiabetesinalloxaninduceddiabeticratscurrenttherapeuticresearchvolume952021100647 AT kamalsherifa corrigendumtoprotectiveroleofsarpogrelateincombinationwithbromocriptineandcabergolinefortreatmentofdiabetesinalloxaninduceddiabeticratscurrenttherapeuticresearchvolume952021100647 AT sindiikhlas corrigendumtoprotectiveroleofsarpogrelateincombinationwithbromocriptineandcabergolinefortreatmentofdiabetesinalloxaninduceddiabeticratscurrenttherapeuticresearchvolume952021100647 |